Corealis Pharma will be attending LSX Congress USA 2026, taking place September 23–24 at the Hynes Convention Center in Boston. As part of Biotech Week Boston, LSX Congress USA brings together biotech executives, pharmaceutical leaders, investors, and strategic partners for high-value partnering, investment, and business development discussions focused on accelerating innovation and company growth.

David Leroux-Petersen and David Kwajewski will be attending on behalf of Corealis and look forward to meeting with biotechnology and pharmaceutical companies seeking experienced development and manufacturing partners for oral solid dose programs. From early formulation development and analytical services to GMP clinical manufacturing and clinical supply, Corealis provides integrated solutions designed to help sponsors reduce development risk and accelerate timelines.

If you'll be attending LSX Congress USA, connect with David and David to discuss your development goals and explore how Corealis can support your path from molecule to clinic.